Posted in | News | Biofuels | Renewable Energy

Renewable Energy Group Enters Agreement for Syntroleum Acquisition

Renewable Energy Group, Inc.® and Syntroleum Corporation announced today that they have entered into an asset purchase agreement pursuant to which REG would acquire substantially all of the assets of Syntroleum Corporation, and assume substantially all of the material liabilities of Syntroleum.

The terms of the transaction call for Syntroleum to receive 3,796,000 shares of REG common stock (subject to reduction in the event that the aggregate market value of the REG common stock to be issued would exceed $49 million or if the cash transferred to REG is less than $3.2 million).

Based in Tulsa, Oklahoma, Syntroleum has pioneered Fischer-Tropsch gas-to-liquids and renewable diesel fuel technologies and has 101 patents issued or pending. Syntroleum also owns a 50% interest in Dynamic Fuels, LLC, a 75-million gallon renewable diesel production facility in Geismar, Louisiana. REG, headquartered in Ames, Iowa, owns and operates eight active biodiesel refineries in four states with a combined nameplate production capacity of 257 million gallons and distributes biodiesel through a national network of distribution terminals.

“Combining Syntroleum’s renewable and synthetic fuel technologies with REG’s expertise in biodiesel production, sales, marketing and logistics should be a positive outcome for investors in both companies,” said Renewable Energy Group, Inc. President and Chief Executive Officer Daniel J. Oh. “This will help us grow our advanced biofuel business, enhance our intellectual property portfolio, expand our geographic footprint and launch REG into new customer segments.”

”Syntroleum and its 50%-owned subsidiary Dynamic Fuels represent an attractive entry path for REG into renewable diesel,” Oh continued. “They have invested substantial resources in their Bio-Synfining technology, which enables the economical conversion of lipid-based biomass into diesel and jet fuel. Their technology and products complement our core biodiesel business.”

Syntroleum’s Board of Directors unanimously approved the asset purchase agreement and recommends that Syntroleum stockholders vote in favor of the transactions contemplated by the asset purchase agreement at a special meeting of stockholders to be convened for that purpose.

“Today’s announcement marks the culmination of our comprehensive process to review Syntroleum’s strategic alternatives to enhance shareholder value,” said Syntroleum President and CEO, Gary Roth. “We are extremely pleased to have found a great partner in REG and to provide our stockholders with the opportunity to participate in a company with significant upside potential. We are confident that REG’s multi-feedstock business model and the combination of our strong management teams will drive increased value for Syntroleum’s stockholders and is the best path forward for Syntroleum. Both of our companies strive to provide consumers with an array of high quality, cleaner-burning fuels and this deal will help to make that happen on a larger scale.”

Syntroleum’s Board of Directors also has approved a plan of dissolution for Syntroleum pursuant to which Syntroleum will be liquidated and dissolved, in accordance with Delaware law, following consummation of the asset sale and subject to stockholder approval of the plan of dissolution at the special meeting. Before distributing any amounts to its stockholders, Syntroleum must satisfy all of its obligations not being assumed by REG, as well as pay certain costs, including employee expenses and expenses associated with the asset sale and the dissolution. The asset purchase agreement with REG provides for Syntroleum to retain a cash reserve equal to the lesser of $5.3 million or the amount of cash on hand at Syntroleum as of the closing, which Syntroleum will use to satisfy these obligations and expenses. Syntroleum currently intends to distribute all of the shares of REG common stock received in the asset sale to Syntroleum’s stockholders, assuming that the cash reserve is sufficient to discharge Syntroleum’s obligations and expenses, which would result in Syntroleum stockholders receiving 0.3809 shares of REG common stock for each outstanding share of Syntroleum common stock (subject to reduction in the event that the aggregate market value of the REG common stock to be issued would exceed $49 million or if the cash transferred to REG is less than $3.2 million). However, it is possible that, in the course of the dissolution process, unanticipated expenses and liabilities will arise. If such liabilities exceed the cash reserve, Syntroleum will be required to sell a portion or all of the REG common stock received in the asset sale to satisfy its obligations before its dissolution, thereby reducing, and perhaps eliminating, the assets available for distribution to Syntroleum stockholders.

Syntroleum plans to convene a special meeting of stockholders to vote upon the approval of the asset sale, the liquidation and dissolution of Syntroleum following completion of the asset sale, and a change in Syntroleum’s name as required by the asset purchase agreement. Syntroleum will distribute to its stockholders a definitive proxy statement/prospectus providing further information about the proposed transactions and the proposals to be considered at the special meeting. The asset sale and subsequent liquidation and dissolution of Syntroleum are conditioned on approval by Syntroleum’s stockholders and the asset sale is further conditioned on the satisfaction of a variety of other closing conditions. The asset sale is expected to close in the first quarter of 2014, subject to satisfaction or waiver of the closing conditions.

Syntroleum will discuss the proposed transactions during its annual meeting of stockholders, which will take place on December 18, 2013, at 2:00 p.m. Central Time. The annual meeting will be held via live webcast at: www.virtualshareholdermeeting.com/SYNM13. A link to a digital archive of the annual meeting webcast will be available on Syntroleum’s website 24 hours after the annual meeting has concluded. Additional information about the transaction will be contained in an investor presentation that will be used at the annual meeting of stockholders and filed by Syntroleum with the United States Securities and Exchange Commission (“SEC”). Interested parties should visit the SEC’s website at www.sec.gov.

Piper Jaffray acted as the sole financial advisor to Syntroleum.

The description of the transaction contained herein is only a summary and is qualified in its entirety by reference to the definitive asset purchase agreement relating to the transaction, a copy of which will be filed by REG and Syntroleum with the SEC as an exhibit to a Current Report on Form 8-K.

Source: http://www.regi.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Syntroleum. (2019, March 01). Renewable Energy Group Enters Agreement for Syntroleum Acquisition. AZoCleantech. Retrieved on April 19, 2024 from https://www.azocleantech.com/news.aspx?newsID=19373.

  • MLA

    Syntroleum. "Renewable Energy Group Enters Agreement for Syntroleum Acquisition". AZoCleantech. 19 April 2024. <https://www.azocleantech.com/news.aspx?newsID=19373>.

  • Chicago

    Syntroleum. "Renewable Energy Group Enters Agreement for Syntroleum Acquisition". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=19373. (accessed April 19, 2024).

  • Harvard

    Syntroleum. 2019. Renewable Energy Group Enters Agreement for Syntroleum Acquisition. AZoCleantech, viewed 19 April 2024, https://www.azocleantech.com/news.aspx?newsID=19373.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.